David F.

David F. has extensive work experience in academia and the medical field. David started their career in 1981 at the University of Pittsburgh as a Professor, where they remained until 2015. In 1996, they became a Professor and Director at the University of Pittsburgh Graduate School of Public Health, holding both positions until 2016 and 2014 respectively. Since then, they have had various roles, including Laboratory Director at Ariel Precision Medicine from 2017 and at SignatureDx from 2021. In 2019, they became the Chief Scientific Officer at Rezq Bio. Additionally, they are a co-founder and member of the Scientific Advisory Board at Diavacs since its establishment in 2013, focusing on developing a dendritic cell-based therapy for type I diabetes patients.

David F. completed their Bachelor of Science (BS) degree in Physics from the University of Pittsburgh from 1965 to 1968. David then pursued their medical education at the University of Pittsburgh School of Medicine, earning their Doctor of Medicine (MD) degree between 1968 and 1972.